| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/11/2008 | EP1928862A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 06/11/2008 | EP1928860A1 Novel 2,3-dihydroindole compounds |
| 06/11/2008 | EP1928461A1 Pyrimidine compounds as serotonin receptor modulators |
| 06/11/2008 | EP1771446B1 Azaindole inhibitors of mtp and apob |
| 06/11/2008 | EP1603908B1 Quinazoline derivatives as tgf-beta inhibitors |
| 06/11/2008 | EP1565463B1 Imidazo[1,5a] pyridine derivatives and methods for treating aldosterone mediated diseases |
| 06/11/2008 | EP1497293B1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | CN101198869A Agent for preventing and treating pancreatitis |
| 06/11/2008 | CN101198613A Substituted tetrahydroquinoline |
| 06/11/2008 | CN101198607A Phenylacetamides suitable as protein kinase inhibitors |
| 06/11/2008 | CN101198595A Aspartyl protease inhibitors |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/11/2008 | CN100394309C Electrophotographic photoreceptor containing naphthalenetetracarboxylic acid diimide derivatives and electrophotographic imaging apparatus employing the same |
| 06/11/2008 | CN100393720C Cyclic benzimidazoles |
| 06/11/2008 | CN100393714C Gyrase inhibitors and uses thereof |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7385056 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 06/10/2008 | US7384965 Fused heterocyclic derivatives as PPAR modulators |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384955 N-[1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-2,2-dimethyl-propanamide; cannabinoid CB1/CB2 receptor agonists; analgesic; in therapy, in particular in the management of pain |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | CA2322790C Granulatimide derivatives for use in cancer treatment |
| 06/05/2008 | WO2008067481A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | WO2008067445A2 Poly(oxyalkylene)ated colorants and their use as fluorescent security taggants |
| 06/05/2008 | WO2008067167A1 Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 06/05/2008 | WO2008066358A1 New compounds and organic light emitting diode using the same |
| 06/05/2008 | WO2008066187A1 Polynuclear complex |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | WO2008065785A1 Novel compound having affinity for amyloid |
| 06/05/2008 | WO2008065199A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/05/2008 | WO2008065198A1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/05/2008 | WO2008065054A1 Tricyclic indoles and (4,5-dihydro) indoles |
| 06/05/2008 | WO2008064830A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses |
| 06/05/2008 | WO2008064823A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses |
| 06/05/2008 | WO2008048683A3 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo[4,5-c]quinolin-4-phthalimide intermediates |
| 06/05/2008 | WO2008044144A3 Chiral tetra-hydro beta-carbolic derivatives and applications thereof as antiparasitic compounds |
| 06/05/2008 | WO2008043791A3 Thiophene derivatives for treating hepatitis c |
| 06/05/2008 | WO2008021346B1 Pure paliperidone and processes for preparing thereof |
| 06/05/2008 | WO2008012782A3 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 06/05/2008 | WO2008005295A3 Modulators of muscarinic receptors |
| 06/05/2008 | US20080132702 Method Of Reducing Alpha, Beta Unsaturated Ketones In Opioid Compositions |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132536 treatment or prophylaxis of inflammatory or allergic diseases chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, allergic rhinitis or atopic dermatitis; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[1-(2,4-dimethylphenyl)propyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide |
| 06/05/2008 | US20080132528 Kinase inhibitors and methods for using the same |
| 06/05/2008 | US20080132525 isoforms DNMT1 and DNMT3b2; for example: 2-amino-4-(((2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(phenethylamino)-9H-purin-9-yl)-tetrahydrofuran-2-yl)methylthio)butanoic acid |
| 06/05/2008 | US20080132516 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 06/05/2008 | US20080132515 Substituted Azaquinazolines Having an Antiviral Action |
| 06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
| 06/05/2008 | US20080132491 Indazole-carboxamide compounds |
| 06/05/2008 | US20080132486 Ligands for Nicotinic Acetylcholine Receptors, and Methods of Making and Using Them |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/05/2008 | DE102006056397A1 Molecular turnstile systems e.g. useful for isotope separation comprise a benzene ring bonded to a 5-membered ring |
| 06/05/2008 | CA2672327A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | CA2671080A1 Carboxylic acid derivatives |
| 06/05/2008 | CA2670858A1 Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 06/05/2008 | CA2670436A1 Novel compound having affinity for amyloid |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/04/2008 | EP1926826A2 Class iia histone deacetylase (hdac) substrate |
| 06/04/2008 | EP1926731A2 Amino-aza-adamantane derivatives and methods of use |
| 06/04/2008 | EP1926730A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | EP1926719A2 2-aniline-4-aryl substituted thiazole derivatives |
| 06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | CN101193890A Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 06/04/2008 | CN101193889A Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
| 06/04/2008 | CN101193888A Synthesis of pyrroloquinoline quinone (PQQ) |
| 06/04/2008 | CN101193868A Pyrimidine derivatives for the treatment of GABA B mediated nervous system disorders |
| 06/04/2008 | CN101193862A Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 06/04/2008 | CN101193637A Flruoro amino alkyl-4-oxo-3,4-dihydropyrido [3,4-d] pyrimidine compounds as mitotic kinesin inhibitors |
| 06/04/2008 | CN101190925A Copper complex, preparation method and application thereof |
| 06/04/2008 | CN101190915A Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application |
| 06/04/2008 | CN101190914A 16-site substituted double functional group huperzine B derivative, preparation method and use thereof |
| 06/04/2008 | CN100391958C Chemical compounds |
| 06/03/2008 | US7381824 Quinoline derivatives |
| 06/03/2008 | US7381741 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 06/03/2008 | US7381733 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 06/03/2008 | US7381732 inhibitors of trypsin-like serine proteases; anticoagulant agents to treat thromboembolic disorders; |
| 06/03/2008 | US7381725 Pyridazine derivatives as ligands for GABA receptors |
| 06/03/2008 | US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 06/03/2008 | US7381537 Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2339934C Medicine for multiple sclerosis |
| 05/29/2008 | WO2008064265A2 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 05/29/2008 | WO2008064093A2 Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 05/29/2008 | WO2008063888A2 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 05/29/2008 | WO2008063668A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008063609A2 Diimide-based semiconductor materials and methods of preparing and using the same |
| 05/29/2008 | WO2008062182A1 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents |
| 05/29/2008 | WO2008062026A1 5-sulfanylmethyl-pyrazolo [1,5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 05/29/2008 | WO2008061741A1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2008012440A3 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 05/29/2008 | US20080125593 Low driving voltages, high efficiencies, high luminance, long life-times and low power consumption; compound are anthracenes substituted with imidazo(1,2-a)pyridine ring(s); OLEDS; high electron transport capabilities |